Pathology of lung cancer

Journal of Thoracic Imaging

Volumn 15, Issue 1, 2000, Pages 3-12

  Franklin, Wilbur A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Diagnosis; Immunohistochemistry; Lung neoplasms; Pathology; Premalignant disorders

Indexed keywords

TUMOR MARKER;

ARTICLE; BRONCHOSCOPY; CANCER CLASSIFICATION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS;

EID: 0033980907     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005382-200001000-00003     Document Type: Article

References (34)

1. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:Suppl:225S-233S.
2. Minna JD, Pass H, Glatstein E, Ihde DC. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, vol 1. Philadelphia: J.B. Lippincott Co., 1989:591-705.
3. Steele JD. The solitary pulmonary nodule. J Thorac Cardiovasc Surg 1963;46:21-39.
4. Cortese DA, Pairolero PC, Bergstralh EJ, et al. Roentgenographically occult lung cancer. A ten-year experience. J Thorac Cardiovasc Surg 1983;86:373-80.
5. Flehinger BJ, Melamed MR. Current status of screening for lung cancer. Chest Surg Clin N Am 1994;4:1-15.
6. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner [see comments]. Lancet 1998;351:1242-5.
7. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening [see comments]. Lancet 1999;354:99-105.
8. Erozan YS, Frost JK. Cytopathologic diagnosis of cancer in pulmonary material: a critical histopathologic correlation. Acta Cytol 1970;14:560-5.
9. Johnston WW, Elson CE. Respiratory Tract. In: Bibbo M, ed. Comprehensive Cytopathology. Philadelphia, London, Toronto, Monteal, Sydney, Tokyo: W.B. Saunders, 1991:320-98.
10. Travis WD, Linder J, Mackay B. Classification, Histology, Cytology and Electron Microscopy. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, eds. Lung Cancer. Principles and Practice. Philadelphia, New York: Lippincott-Raven Publishers, 1996:361-95.
11. Bedrossian CW, Rybka DL. Bronchial brushing during fiberoptic bronchoscopy for the cytodiagnosis of lung cancer: comparison with sputum and bronchial washings. Acta Cytol 1976;20:446-53.
12. Johnston WW, Bossen EH. Ten years of respiratory cytopathology at Duke University Medical Center. I. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol 1981;25: 103-7.
13. Ng AB, Horak GC. Factors significant in the diagnostic accuracy of lung cytology in bronchial washing and sputum samples. II. Sputum samples. Acta Cytol 1983;27:397-402.
14. Truong LD, Underwood RD, Greenberg SD, McLarty JW. Diagnosis and typing of lung carcinomas by cytopathologic methods. A review of 108 cases. Acta Cytol 1985;29:379-84.
15. Tanaka T, Yamamoto M, Tamura T, et al. Cytologic and histologic correlation in primary lung cancer. A study of 154 cases with resectable tumors. Acta Cytol 1985;29:49-56.
16. DeMay RM. Lung. In: DeMay RM, ed. The Art and Science of Cytopathology: Aspiration Cytology. Chicago: ASCP Press, 1996: 947-98
17. DeMay RM. Respiratory Cytology. In: DeMay RM, ed. The Art and Science of Cytopathology. Chicago: ASCP Press, 1996:207-56.
18. Yankelevitz DF, Henschke CI, Koizumi JH, Altorki NK, Libby D. CT-guided transthoracic needle biopsy of small solitary pulmonary nodules. Clin Imaging 1997;21:107-10.
19. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Tumours of Lung and Pleura. 3rd edition. World Health Organization International Classification of Tumours. Sobin, L. H. Ref Type: Serial (Book, Monograph). Berlin, Heidelberg, New York: Springer-Verlag, 1999.
20. Anonymous. Histological Typing of Lung Tumours. 2nd(1). 1981. Geneva, World Health Organization. International histological classification of tumours. Ref Type: Serial (Book, Monograph)
21. Hammar SP. Common Neoplasms. In: Dail DH, Hammar SP, eds. Pulmonary Pathology. New York: Springer Verlag, 1994:1123-278.
22. Mooi W. Common lung cancers. In: Hasleton PS, ed. Spencer's Pathology of the Lung. New York: McGraw-Hill, 1996:1009-64.
23. Colby TV, Koss MN, Travis WD. Tumors of the lower respiratorytract. Rosai J. 3rd(Fascicle 13). Atlas of Tumor Pathology. Ref Type: Serial (Book,Monograph). Washington, D.C.: Armed Forces Institute of Pathology, 1995.
24. Cagle PT. Tumors of the lung (excluding lymphoid tumors). In: Thurlbeck WM, Churg AM, eds. Pathology of the Lung. New York: Thieme Medical Publishers, Inc., 1995:437-551.
25. Horwitz SB. Taxol: mechanisms of action and resistance. Jm Natl Cancer Inst Monogr 1993;55-61.
26. Manfredi JJ. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 1984;25:83-125.
27. Schiff PB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980;77:1561-65.
28. Schiff PB. Promotion of microtubule assembly in vitro by taxol. Nature 1979;277:665-7.
29. Hruban RH, Yardley JH, Donehower RC, Boitnott JK. Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer 1989;63:1944-50.
30. Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995;92:9176-80.
31. Saccomanno G. Diagnostic Pulmonary Cytology. Chicago: American Society of Clinical Pathologists, 1978:33-46.
32. Anonymous. The World Health Organization histological typing of lung tumours. Second edition. American Journal of Clinical Pathology 1982;77:123-36.
33. Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 1993;11:1757-62.
34. Franklin WA, Keith RL, Varella-Garcia M, et al. Molecular abnormalities and micropapillary histological lesions in bronchial epithelium of smokers at risk for lung cancer. Proc Amer Assoc Cancer Res 1998;39:125. abstract.